Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients

ClinicalTrials.gov ID: NCT00220766

Public ClinicalTrials.gov record NCT00220766. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

IGIV-C 10% Rapid Infusion Trial in Primary Immune Deficient Patients

Study identification

NCT ID: NCT00220766
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Grifols Therapeutics LLC; Industry
Enrollment: 100 participants

Conditions and interventions

Conditions

Interventions

Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified Drug
Dextrose, 5% in Water Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 75 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 31, 2002
Primary completion: Jul 31, 2002
Completion: Feb 29, 2004
Last update posted: Sep 24, 2009

2002 – 2004

United States locations

U.S. sites: 9
U.S. states: 7
U.S. cities: 9

Facility	City	State	ZIP	Site status
Departments of Medicine and Microbiology	Birmingham	Alabama	35294	—
National Jewish Medical and Researach Center	Denver	Colorado	80206	—
International Center for Interdisciplinary Studies of Immunology	Washington D.C.	District of Columbia	20007	—
Allergy Associates of the Palm Beaches	North Palm Beach	Florida	33408	—
University of South Florida College of Medicine	St. Petersburg	Florida	33701	—
The Clinical Trials Center, Children's Hospital	New Orleans	Louisiana	70118	—
Allergy, Asthma, and Immunology	Omaha	Nebraska	68124	—
University Hospitals of Cleveland	Cleveland	Ohio	44106	—
Optimed Research, LLC	Columbus	Ohio	43235	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00220766, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 24, 2009 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00220766 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →